The Global Fund's leadership on harm reduction: 2002-2009.

[1]  Matthew Hickman,et al.  Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review , 2008, The Lancet.

[2]  Martin McKee,et al.  Health systems' responses to 25 years of HIV in Europe: inequities persist and challenges remain. , 2008, Health policy.

[3]  T. Rhodes,et al.  Access to syringes in three Russian cities: implications for syringe distribution and coverage. , 2008, The International journal on drug policy.

[4]  A. Ball.  HIV, injecting drug use and harm reduction: a public health response. , 2007, Addiction.

[5]  G. Stimson.  "Harm reduction--coming of age": a local movement with global impact. , 2007, The International journal on drug policy.

[6]  Anya Sarang,et al.  Implementation of harm reduction in Central and Eastern Europe and Central Asia. , 2007, The International journal on drug policy.

[7]  Mukta Sharma,et al.  Coverage of HIV prevention programmes for injection drug users: confusions, aspirations, definitions and ways forward. , 2007, The International journal on drug policy.

[8]  A. Wodak.  Controlling HIV among injecting drug users: the current status of harm reduction. , 2006, HIV/AIDS policy & law review.

[9]  Lorrae van Kerkhoff,et al.  Linking local knowledge with global action: examining the Global Fund to Fight AIDS, Tuberculosis and Malaria through a knowledge system lens. , 2006, Bulletin of the World Health Organization.

[10]  Matthew Hickman,et al.  Global overview of injecting drug use and HIV infection among injecting drug users , 2004, AIDS.

[11]  Nikhil Dutta,et al.  Global Fund To Fight AIDS, Tuberculosis, And Malaria , 2010 .